Results 31 to 40 of about 62,089 (270)

Therapeutic efficacy of macrolides in management of patients with mild COVID-19

open access: yesScientific Reports, 2021
Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive
Alaa Rashad   +9 more
doaj   +1 more source

High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong [PDF]

open access: yes, 2000
Background: Metronidazole resistance is a common problem in most Asian countries, and clarithromycin has been widely used in Hong Kong. Aim: To determine the prevalence of Helicobacter pylori strains resistant to metronidazole and clarithromycin in Hong ...
Berg, DE   +9 more
core   +1 more source

Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results [PDF]

open access: yesТерапевтический архив, 2020
Aim. Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian Federation. Materials and methods. As part of a clinical laboratory study, from 2015 to 2018,
I. V. Maev   +15 more
doaj   +1 more source

Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutic options [PDF]

open access: yes, 2008
Infection and inflammation may have a crucial role in the pathogenesis of atherosclerosis. This hypothesis is supported by an increasing number of reports on the interaction between chronic infection, inflammation, and atherogenesis.
Abbas, M.A.   +6 more
core   +1 more source

Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization [PDF]

open access: yes, 2017
We conducted a study to determine the main traits of pertussis among unimmunized infants less than 6 months of age. From August 2012 to March 2015, 141 nasopharyngeal aspirates (NPAs) were collected from infants with respiratory symptoms attending 2
Buttinelli, Gabriele   +12 more
core   +1 more source

Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin

open access: yesCase Reports in Oncology, 2023
We encountered a case in which the general condition of a patient receiving cabazitaxel worsened with concomitant use of clarithromycin. Cabazitaxel is metabolized mainly by CYP3A4, and the frequency of adverse events is known to increase with increasing
Shigeaki Katsumi   +5 more
doaj   +1 more source

Infection With Mycobacterium chelonae Following Autologous Facial Fat Grafting: A Case Report and Review of Literature. [PDF]

open access: yesJ Cosmet Dermatol
ABSTRACT Background Autologous fat grafting is commonly used in cosmetic dermatology, but it can cause serious complications, including nontuberculous mycobacterial infections when done under unsterile conditions. Case Presentation We report a 39‐year‐old woman who developed multiple discharging facial abscesses 1 month after undergoing autologous fat ...
Alavi Darazam I   +4 more
europepmc   +2 more sources

Changes of Interleukins in Patients with Nosocomial Pneumonia Against a Background of Traumatic Brain Injury: Role in the Diagnosis and Monitoring of Disease [PDF]

open access: yes, 2017
Introduction. Nosocomial pneumonia (NP) is the second leading frequency and mortality among nosocomial infections. NP is a frequent complication of severe traumatic brain injury (TBI).
Ilchenko, A. (Anastasiia)
core   +2 more sources

Poly(lactic acid)/clarithromycin with metals dioxides nanoparticles: Preparation and performance under ultraviolet irradiation

open access: yesMaterials Science for Energy Technologies
Different polylactic acid (PLA) thin films containing clarithromycin and a number of metal oxide nanoparticles (magnesium, titanium, zinc, and nickel) dioxides were created. Low dosages of metal oxides (0.01% by weight) and clarithromycin (0.5% by weight)
Hadeel Adil   +8 more
doaj   +1 more source

Polymorphism of virulence genes and biofilm associated with in vitro induced resistance to clarithromycin in Helicobacter pylori

open access: yesGut Pathogens, 2023
Background Clarithromycin-containing triple therapy is commonly used to treat Helicobacter pylori infections. Clarithromycin resistance is the leading cause of H. pylori treatment failure. Understanding the specific mutations that occur in H.
Naim Asyraf Rosli   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy